Therapeutic Drugs External Quality Assessment

Home - Therapeutic Drugs External Quality Assessment

Therapeutic Drugs External Quality Assessment

The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.

  • Accredited to ISO/IEC 17043
  • Lyophilised for enhanced stability
  • 100% human serum
  • Bi-weekly reporting
  • Submit results and view reports online via RIQAS.Net
  • Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
  • Weighed in values reported for each parameter
Cat NoKit SizeFrequencyCycle StartParameters
RQ911112 x 5mlBi-weekly (2 x 6 monthly cycles)March / Sept18
MS500720 x 5ml N/AN/AN/A


  • Amikacin
  • Caffeine
  • Carbamazepine
  • Cyclosporine
  • Digoxin
  • Ethosuximide
  • Gentamicin
  • Lithium
  • Methotrexate
  • Paracetamol
  • Phenobarbital
  • Phenytoin
  • Primidone
  • Salicylic Acid
  • Theophylline
  • Tobramycin
  • Valproic Acid
  • Vancomycin

Please note, product availability may vary country to country.